Metropolis Healthcare Limited Share Price & Stock Analysis

Metropolis Healthcare Limited (NSE: METROPOLIS, BSE: 542650) is a Mumbai, Maharashtra-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹11,952 Cr, it ranks #541 by market cap among the 6,197 Indian listed companies on FinBizNet, and #3 of 18 in Medical Diagnostic Centres. At ₹565.00 (as of 16 Nov 2026), the share price is 7.2% below its 52-week high of ₹609.05 and 37.1% above its 52-week low of ₹412.25. The share price is up 14.9% over one year and up 1.0% over three months.

Key Metrics

Current Price₹565.00
Market Cap₹11,952 Cr
NSE SymbolMETROPOLIS
BSE Code542650
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Services > Medical Diagnostic Centres
P/E Ratio61.5
Return on Equity13.37%
Return on Assets8.36%
52-Week Range₹412.25 – ₹609.05
1-Year Price Change+14.9%
3-Month Price Change+1.0%
Beta (1Y)0.76
Dividend Yield0.35%
HeadquartersMumbai, Maharashtra
Websitewww.metropolisindia.com

Latest Quarterly Results — Q2 FY27

Revenue₹497 Cr
Net Profit₹75 Cr
Net Margin15.2%
EPS (Basic)₹3.64
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Metropolis Healthcare Limited Quarterly Revenue and Profit Trend

Metropolis Healthcare Limited reported revenue of ₹497 Cr in Q2 FY27, up 15.8% from ₹429 Cr in Q2 FY26 and up 10.4% from ₹450 Cr in Q1 FY27. It posted a net profit of ₹75 Cr for the quarter, against a net profit of ₹53 Cr in Q2 FY26 (up 42.7%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹345 Cr (Q4 FY25) to ₹497 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹497 Cr₹75 Cr15.2%
Q1 FY27₹450 Cr₹57 Cr12.6%
Q4 FY26₹425 Cr₹51 Cr12.0%
Q3 FY26₹406 Cr₹42 Cr10.4%
Q2 FY26₹429 Cr₹53 Cr12.3%
Q1 FY26₹386 Cr₹45 Cr11.7%
Q4 FY25₹345 Cr₹29 Cr8.5%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 47.82% of Metropolis Healthcare Limited's shares as of Sept 2026, against 48.89% in Sept 2025 (−1.07 percentage points). Delivery averaged 53.4% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Metropolis Healthcare Limited

Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinical trial research, hospital lab management, and home collection services, as well as profiles, blood tests, and soft radiology services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, youth, and corporates. In addition, the company develops and deals in technology driven products and services. The company serves a range of customers, including direct-to-consumer diagnostics through patient service centers, a mobile app, a website, and home collection; partnerships with standal

Products and Services

1. Pathology Service-This segment provides pathology and related healthcare services.

Business Segments

1. Pathology Service-100%

Metropolis Healthcare Limited vs Peers — Medical Diagnostic Centres

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Dr. Lal Pathlabs Ltd₹33,934 Cr66.421.48%₹874 Cr+28.7%
Vijaya Diagnostic Centre Limited₹14,665 Cr84.319.70%₹255 Cr+38.5%
Metropolis Healthcare Limited₹11,952 Cr61.513.37%₹497 Cr+14.9%
Throcare Technologies Ltd₹7,764 Cr47.628.74%₹271 Cr+7.5%
SURAKSHA DIAGNOSTIC LIMITED₹1,856 Cr55.413.84%₹99 Cr+6.9%
Krsnaa Diagnostics Ltd₹1,625 Cr16.810.89%₹271 Cr-27.0%
Gaudium IVF and Women Health Limited₹803 Cr27.416.08%₹37 Cr—
Chandan Healthcare Limited₹582 Cr21.918.43%₹81 Cr—
Aspira Pathlab & Diagnostics Ltd₹127 Cr2,360——+115.2%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Metropolis Healthcare Limited?

Metropolis Healthcare Limited is trading at ₹565.00, with a market capitalisation of ₹11,952 Cr.

Which sector does Metropolis Healthcare Limited belong to?

Metropolis Healthcare Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).

What are the key financial ratios of Metropolis Healthcare Limited?

Metropolis Healthcare Limited has a P/E of 61.5 and a return on equity of 13.37%.

What is the stock symbol of Metropolis Healthcare Limited?

Metropolis Healthcare Limited is listed on the NSE under the symbol METROPOLIS and on the BSE under the scrip code 542650.

How has Metropolis Healthcare Limited's share price moved over the past year?

Metropolis Healthcare Limited's share price is up 14.9% over one year and up 1.0% over three months. Its 52-week range is ₹412.25 to ₹609.05.

What were Metropolis Healthcare Limited's latest quarterly results?

In Q2 FY27, Metropolis Healthcare Limited reported revenue of ₹497 Cr and net profit of ₹75 Cr, with basic EPS of ₹3.64 (consolidated, parsed from the company's exchange filing).

How have Metropolis Healthcare Limited's revenue and profit changed over the past year?

Metropolis Healthcare Limited reported revenue of ₹497 Cr in Q2 FY27, up 15.8% from ₹429 Cr in Q2 FY26 and up 10.4% from ₹450 Cr in Q1 FY27.

What is the promoter holding in Metropolis Healthcare Limited?

Promoters held 47.82% of Metropolis Healthcare Limited's shares as of Sept 2026, against 48.89% in Sept 2025 (−1.07 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.